Outcomes of retained gastrointestinal debris during upper endoscopy

Abstract

Background and study aims

Gastrointestinal debris retention (GIDR) during endoscopy can result in aborted procedures, intubation, and aspiration. GIDR has increased significance with uptake of glucagon-like peptide-1 receptor agonist (GLP-1RA) use. Outcome analysis is vital to risk-stratify patients with GIDR during endoscopy. Our study evaluated the effect of GIDR on endoscopic complications.

Patients and methods

This was a retrospective review of patients who underwent endoscopy between May 2016 and December 2021 with documented GIDR. The study included 138 patients with GIDR and 275 controls. Propensity score matching between patients with GIDR and controls was performed in a 1:2 ratio based on age, sex, body mass index (BMI), and American Society of Anesthesiologists (ASA) status. T-tests and chi square tests were used to compare continuous and categorical variables.

Results

The GIDR group was younger and had lower BMI, with no difference in sex, race, American Society of Anesthesiologists status, or use of monitored anesthesia care. GIDR was more frequently encountered when indications were abnormal imaging, pain, and pancreatico-biliary. Amount of GIDR was quantified as “large” in 37.7% of cases and size of debris was associated with rate of aborted procedures.

Conclusions

Our study did not demonstrate a significant increase in post-procedure complications in patients with GIDR. Further, the GIDR group had higher rates of opiate use, which can guide stratification of retention risk.

Keywords

Endoscopy Upper GI Tract - Motility / achalasia - Quality and logistical aspects - Performance and complications

Publikationsverlauf

Eingereicht: 23. Mai 2024

Angenommen nach Revision: 18. Februar 2025

Accepted Manuscript online:
21. Februar 2025

Artikel online veröffentlicht:
04. April 2025

• References

• 1 Saied N, Chopra A, Agarwal B. Parenteral erythromycin for potential use to empty retained gastric contents encountered during upper gastrointestinal endoscopic procedures. Open J Gastroenterol 2012; 2: 119
• 2 Aldawsari M, Almadani FA, Almuhammadi N. et al. The efficacy of glp-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: systematic review of randomized controlled trials. Diabetes Metab Syndr Obes 2023; 16: 575-595
• 3 The American Society of Anesthesiologists Task Force on Preoperative Fasting. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures. Anesthesiology 2017; 126: 376-393
• 4 Prout BJ, Metreweli C. Pulmonary aspiration after fibre-endoscopy of the upper gastrointestinal tract. Br Med J 1972; 4: 269-271
• 5 Thomson A, Tye-Din J, Tonga S. et al. Aspiration in the context of upper gastrointestinal endoscopy. Can J Gastroenterol 2007; 21: 223-225
• 6 Lipper B, Simon D, Cerrone F. Pulmonary aspiration during emergency endoscopy in patients with upper gastrointestinal hemorrhage. Crit Care Med 1991; 19: 330-333
• 7 Firkins SA, Yates J, Shukla N. et al. Clinical outcomes and safety of upper endoscopy while on glucagon-like peptide-1 receptor agonists. Clin Gastroenterol Hepatol 2024; S1542356524002957
• 8 Ushakumari DS, Sladen RN. Asa consensus-based guidance on preoperative management of patients on glucagon-like peptide-1 receptor agonists. Anesthesiology 2024; 140: 346-348
• 9 Hashash JG, Thompson CC, Wang AY. Aga rapid clinical practice update on the management of patients taking glp-1 receptor agonists prior to endoscopy: communication. Clin Gastroenterol Hepatol 2024; 22: 705-707
• 10 Coleski R, Baker JR, Hasler WL. Endoscopic gastric food retention in relation to scintigraphic gastric emptying delays and clinical factors. Dig Dis Sci 2016; 61: 2593-2601